Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

The multimedia tool improved patient understanding of PRP treatment for hair loss.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Lentiviral vector effectiveness in skin is influenced by external factors, not receptor availability.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.